Corrie E. Erasmus

3.1k total citations
94 papers, 1.5k citations indexed

About

Corrie E. Erasmus is a scholar working on Neurology, Psychiatry and Mental health and Molecular Biology. According to data from OpenAlex, Corrie E. Erasmus has authored 94 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Neurology, 36 papers in Psychiatry and Mental health and 30 papers in Molecular Biology. Recurrent topics in Corrie E. Erasmus's work include Botulinum Toxin and Related Neurological Disorders (30 papers), Cerebral Palsy and Movement Disorders (29 papers) and Muscle Physiology and Disorders (20 papers). Corrie E. Erasmus is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (30 papers), Cerebral Palsy and Movement Disorders (29 papers) and Muscle Physiology and Disorders (20 papers). Corrie E. Erasmus collaborates with scholars based in Netherlands, United States and United Kingdom. Corrie E. Erasmus's co-authors include Karen van Hulst, Peter H. Jongerius, Imelda J. M. de Groot, Frank J. A. van den Hoogen, L. van den Engel–Hoek, B.J.M. de Swart, Jan J. Rotteveel, Nicol C. Voermans, L.T.L. Sie and Baziel G.M. van Engelen and has published in prestigious journals such as Neurology, Annals of Neurology and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

Corrie E. Erasmus

83 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Corrie E. Erasmus Netherlands 24 596 594 350 294 272 94 1.5k
Enrico Alfonsi Italy 28 362 0.6× 989 1.7× 154 0.4× 97 0.3× 400 1.5× 121 2.3k
Domenico A. Restivo Italy 26 247 0.4× 446 0.8× 250 0.7× 61 0.2× 476 1.8× 71 1.7k
Craig Campbell Canada 22 152 0.3× 213 0.4× 720 2.1× 236 0.8× 42 0.2× 90 1.3k
C Tardieu France 23 671 1.1× 591 1.0× 308 0.9× 74 0.3× 38 0.1× 78 2.4k
Seong‐Woong Kang South Korea 19 71 0.1× 243 0.4× 245 0.7× 300 1.0× 213 0.8× 95 1.3k
Claudia Celletti Italy 30 385 0.6× 322 0.5× 140 0.4× 150 0.5× 18 0.1× 92 2.2k
Sun Gun Chung South Korea 22 355 0.6× 301 0.5× 85 0.2× 78 0.3× 64 0.2× 99 1.8k
B. Mamoli Austria 23 266 0.4× 723 1.2× 247 0.7× 143 0.5× 19 0.1× 113 1.7k
V. Tiffreau France 21 214 0.4× 251 0.4× 252 0.7× 115 0.4× 21 0.1× 63 980
Matthew Pitt United Kingdom 23 185 0.3× 596 1.0× 481 1.4× 292 1.0× 14 0.1× 77 1.7k

Countries citing papers authored by Corrie E. Erasmus

Since Specialization
Citations

This map shows the geographic impact of Corrie E. Erasmus's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Corrie E. Erasmus with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Corrie E. Erasmus more than expected).

Fields of papers citing papers by Corrie E. Erasmus

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Corrie E. Erasmus. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Corrie E. Erasmus. The network helps show where Corrie E. Erasmus may publish in the future.

Co-authorship network of co-authors of Corrie E. Erasmus

This figure shows the co-authorship network connecting the top 25 collaborators of Corrie E. Erasmus. A scholar is included among the top collaborators of Corrie E. Erasmus based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Corrie E. Erasmus. Corrie E. Erasmus is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Evertz, Reinder, Jan T. Groothuis, Baziel G.M. van Engelen, et al.. (2024). Cardiac Involvement in LAMA2-Related Muscular Dystrophy and SELENON-Related Congenital Myopathy: A Case Series. Journal of Neuromuscular Diseases. 11(5). 919–934.
4.
Goselink, Rianne J.M., et al.. (2024). Longitudinal Insights Into Childhood Onset Facioscapulohumeral Dystrophy. Neurology. 104(1). e210059–e210059. 1 indexed citations
5.
6.
Erasmus, Corrie E., et al.. (2024). Social and emotional impact of anterior drooling in school-age children and young people with neurodevelopmental disabilities. European Journal of Pediatrics. 183(10). 4491–4498. 1 indexed citations
7.
Cup, Edith H. C., et al.. (2024). Quality of life and support needs in children, adolescents, and young adults with facioscapulohumeral dystrophy, a mixed-method study. European Journal of Paediatric Neurology. 50. 64–73. 1 indexed citations
8.
Burg, J.J.W. van der, et al.. (2024). The when, why, and how of using glycopyrronium to diminish drooling in children with neurodevelopmental disabilities: Implications for clinical practice. European Journal of Paediatric Neurology. 51. 24–31. 2 indexed citations
9.
Verhoeven, Jamie I., Jürgen Seeger, J. Molenaar, et al.. (2024). Brody Disease, an Early-Onset Myopathy With Delayed Relaxation and Abnormal Gait. Neurology. 102(5). e209164–e209164. 1 indexed citations
10.
Burg, J.J.W. van der, et al.. (2024). Interdisciplinary assessment and treatment of paediatric drooling: two decades of experience by the Nijmegen saliva control team reflected in a stepwise algorithm. European Journal of Pediatrics. 183(9). 3979–3985. 2 indexed citations
11.
Nievelstein, Rutger A. J., Ruben P. A. van Eijk, Fay‐Lynn Asselman, et al.. (2023). Swallowing Problems in Spinal Muscular Atrophy Types 2 and 3: A Clinical, Videofluoroscopic and Ultrasound Study. Journal of Neuromuscular Diseases. 10(3). 427–438. 9 indexed citations
12.
Mul, Karlien, Corrie E. Erasmus, Jan T. Groothuis, et al.. (2023). Psychosocial functioning in patients with altered facial expression: a scoping review in five neurological diseases. Disability and Rehabilitation. 46(17). 3772–3791. 7 indexed citations
13.
Groothuis, Jan T., Peter J. Wijkstra, Baziel G.M. van Engelen, et al.. (2023). Respiratory function in LAMA2-related muscular dystrophy and SELENON-related congenital myopathy, a 1.5-year natural history study. European Journal of Paediatric Neurology. 48. 30–39. 2 indexed citations
14.
Erasmus, Corrie E., et al.. (2023). Best practice recommendations for speech-language pathology in children with neuromuscular disorders: A Delphi-based consensus study. International Journal of Speech-Language Pathology. 26(1). 45–58. 6 indexed citations
15.
Erasmus, Corrie E., Maartje Pennings, Meyke Schouten, et al.. (2021). Clinical, genetic, and histological features of centronuclear myopathy in the Netherlands. Clinical Genetics. 100(6). 692–702. 8 indexed citations
16.
Hulst, Karen van, et al.. (2021). Dysphagia limit in children with cerebral palsy aged 4 to 12 years. Developmental Medicine & Child Neurology. 64(2). 253–258. 9 indexed citations
17.
Bekkers, Stijn, et al.. (2021). Posterior drooling in children with cerebral palsy and other neurodevelopmental disorders. Developmental Medicine & Child Neurology. 63(9). 1093–1098. 12 indexed citations
18.
Böhm, Johann, Maartje Pennings, Meyke Schouten, et al.. (2021). Spectrum of Clinical Features in X-Linked Myotubular Myopathy Carriers. Neurology. 97(5). e501–e512. 7 indexed citations
19.
Goselink, Rianne J.M., Karlien Mul, Richard J.L.F. Lemmers, et al.. (2018). Early onset as a marker for disease severity in facioscapulohumeral muscular dystrophy. Neurology. 92(4). e378–e385. 32 indexed citations
20.
Goselink, Rianne J.M., Karlien Mul, Richard J.L.F. Lemmers, et al.. (2018). A 22-year follow-up reveals a variable disease severity in early-onset facioscapulohumeral dystrophy. European Journal of Paediatric Neurology. 22(5). 782–785. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Enrico Alfonsi Breakdown of academic impact, for papers by Domenico A. Restivo Breakdown of academic impact, for papers by Craig Campbell Breakdown of academic impact, for papers by C Tardieu Breakdown of academic impact, for papers by Seong‐Woong Kang Breakdown of academic impact, for papers by Claudia Celletti Breakdown of academic impact, for papers by Sun Gun Chung Breakdown of academic impact, for papers by B. Mamoli Breakdown of academic impact, for papers by V. Tiffreau Breakdown of academic impact, for papers by Matthew Pitt
Rankless by CCL
2026